Je-Hwan Lee, MD, PhD¹, Hawk Kim, MD, PhD², Young-Don Joo, MD³, Won Sik Lee⁴, Sung Hwa Bae, M.D.⁵, Dae Young Zang^6*, Jihyun Kwon, MD⁷, Min Kyoung Kim⁸, Junglim Lee, MD⁹, Gyeong Won Lee^10*, Jung-Hee Lee, MD, PhD^11*, Yunsuk Choi, MD, PhD^12*, Dae-Young Kim, MD, PhD¹, Sung-Nam Lim, MD,^3*, Sang-Min Lee^4*, Hun-Mo Ryoo, MD⁵, Hyo Jung Kim^6*, Myung Soo Hyun^8* and Kyoo-Hyung Lee, MD, PhD¹

¹Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
²Ulsan University Hospital, Department of Hematology and Oncology, Associate Professor, Ulsan, South Korea
³Haeundae-Paik Hospital / Cancer center / Hematology, Inje University College of Medicine, Busan, South Korea
⁴Department of Hematology, Inje University, Busan Paik Hospital, Busan, South Korea
⁵Internal Medicine, Daegu Catholic University Hospital, Daegu, South Korea
⁶Hallym University Sacred Heart Hospital, Anyang, South Korea
⁷Chungbuk National University Hospital, Cheongju-Si, South Korea
⁸Internal Medicine, Yeungnam University Medical Center, Daegu, South Korea
⁹Department of Internal Medicine, Daegu Fatima Hospital, Daegu, South Korea
¹⁰Gyeongsan National University Hospital, Jinju, South Korea
¹¹Department of Hematology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea
¹²Division of Hematology and Cellular Therapy, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea

Anjali S. Advani, MD¹, William Tse, MD, FACP², Xuefei Jia^3*, Paul Elson, PhD^3*, Brenda Cooper, MD⁴, Francis Ali-Osman^5*, Jino Park, PhD^2*, Arati V. Rao, MD⁶, David A. Rizzieri, MD⁷, Eunice S. Wang, MD⁸, Claudiu V. Cotta, MD^9*, Matt Kalaycio, MD¹⁰, Ronald M. Sobecks, MD¹⁰, Basel Rouphail, MD, MBA^10*, Jaroslaw P. Maciejewski, MD, Ph.D.¹¹, Jaime Fensterl^12*, Laura Bailey, BS^12*, Jennifer S. Carew, Ph.D.¹¹, Bethany Foster^12*, Mary Lynn Rush^12*, Donna Adams^13*, Elizabeth A. Griffiths, MD⁸ and Mikkael A. Sekeres, MD, MS¹

¹Leukemia Program, Cleveland Clinic, Cleveland, OH
²James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY
³Cleveland Clinic, Quantitative Health Sciences, Cleveland, OH
⁴Case Western Reserve University, University Hospitals of Cleveland, Cleveland, OH
⁵Duke University, Durham, NC
⁶Duke Cancer Institute, Duke University, Durham, NC
⁷Dept. of Medicine, Div. of Hematological Malignancies & Cellular Therapy, Duke University Medical Center, Durham, NC
⁸Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
⁹Department of Pathology, Cleveland Clinic, Cleveland, OH
¹⁰Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
¹¹Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
¹²Leukemia Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
¹³Department of Medicine, Duke University, Durham, NC

Pragya Srivastava, PhD^1*, Benjamin E. Paluch^2*, Junko Matsuzaki, PhD^3*, Smitha R. James^2*, Golda Collmat-Lai^2*, Nadja Blagitko-Dorfs^4*, Laurie Ann Ford^1*, Rafeh Naqash, MD^1*, Michael Luebbert, MD^5*, Adam R. Karpf, PhD^6*, Michael J. Nemeth, PhD^1,7 and Elizabeth A. Griffiths, MD^1,2,7

¹Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
²Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY
³Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY
⁴Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany
⁵Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany
⁶Eppley Institute, Fred & Pamela Buffett Cancer Center, Omaha, NE
⁷Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY

Eva Oswald, PhD^1*, Gabriele Greve^2*, Kerstin Klingner^1*, Benedikt Hammerich^3*, Dorothee Lenhard^1*, Milena Pantic, PhD^4*, Michael Luebbert, MD^4* and Julia B. Schueler, DVM, PhD¹

¹Oncotest GmbH, Freiburg, Germany
²Faculty of Biology, University of Freiburg, Freiburg, Germany
³University of Freiburg Medical Center, Freiburg, Germany
⁴Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany

Heeje Kim¹, A-Reum Han^2*, Ji Yoon Lee^3*, Woo-Sung Min^4*, Gyeongsin Park^5*, Se-Hoon Kim^6* and Junglim Lee, MD⁷

¹Cancer Research Institute, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
²Cancer Research Institute, Seoul St. Mary’s Hospital, Catholic Blood and Marrow Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, South Korea
³Cancer Research Institute, Seoul St. Mary’s Hospital, Department of Hematology, Catholic Blood and Marrow Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, South Korea
⁴Seoul St. Mary’s Hospital, Department of Hematology, Catholic Blood and Marrow Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, South Korea
⁵Cancer Research Institute, Seoul St. Mary’s Hospital, Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, South Korea
⁶Daewon Foreign Language High School, Seoul, South Korea
⁷Daegu Fatima Hospital Public Cord Blood Bank, Daegu, South Korea

Jianda Hu, MD, PhD¹, Yi Chen, MD^2*, Xiaoyun Zheng, MD^2*, Zhihong Zheng, MD, PhD^2*, Ting Yang, Prof. MD, PhD^3* and Tingbo LIU, MD, PhD^2*

¹Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
²Fujian Medical University Union Hospital, Fuzhou, China
³Department of Hematology, Union Hospital,Fujian Medical University, Fuzhou, China

Tapan Kadia, MD¹, Jorge E. Cortes, MD², Elias J. Jabbour, MD², Naval Daver, MD², Naveen Pemmaraju, MD², Farhad Ravandi, MD², Nitin Jain, MD², Srdan Verstovsek, MD, PhD², Courtney DiNardo, MD³, Yesid Alvarado, MD², Alessandra Ferrajoli, MD², Jan A Burger, MD, PhD², Guillermo Garcia-Manero, MD², Maro Ohanian, DO^2*, Marina Konopleva, MD, PhD⁴, Zeev Estrov, M.D.², William Wierda, MD, PhD¹, Mark Brandt, BS^1*, Tina Fitch, RN^2*, Gautam Borthakur, MD² and Hagop M. Kantarjian, MD²

¹Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³University of Texas MD Anderson Cancer Center, Houston, TX
⁴Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Helena Boutzen, PharmD PhD^1*, Estelle Saland^2*, Mathilde Cathebras^1*, Clément Larrue, PhD^1*, Thomas Farge^1*, Nizar Serhan, PhD^1*, Fabienne De Toni, PhD^1*, Marion David, PhD^1*, Lara Gales^3*, Florence Castelli^4*, Christophe Junot, PhD^4*, Eric Delabesse, PharmD PhD^1,5*, Demas Veronique, PharmD PhD^1,5*, Jean-Charles Portais, PhD^3*, Ouathek Ouerfelli, PhD^6*, Yang Guangli, PhD^6*, Francois Vergez, VD PhD^1,5*, Christian Recher, MD PhD^1,5 and Jean-Emmanuel Sarry, PhD^2*

¹CRCT, INSERM, Toulouse, France
²INSERM, CRCT, Toulouse, France
³INSA, Toulouse, France
⁴CEA, saclay, France
⁵Institut Universitaire du Cancer, Toulouse, France
⁶Memorial Sloan Kettering Cancer Center, New york, NY

Jonathan Canaani, MD¹, Marlise R. Luskin, MD¹, Alison Loren, MD, MS², Colleen Timlin, PharmD, BCOP^3*, James Mangan, MD, PhD⁴, Elizabeth O. Hexner, MD¹, Noelle V. Frey, MD MS¹, David L Porter, MD¹, Edward A. Stadtmauer, MD¹ and Selina Luger, MD¹

¹Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
³Department of Pharmacy, Hospital of The University of Pennsylvania, Philadelphia, PA
⁴Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA